TY  - JOUR
AU  - Luque, R
AU  - Benavides, M
AU  - Del Barco, S
AU  - Egaña, L
AU  - Garcia-Gomez, J
AU  - Martinez-Garcia, M
AU  - Perez-Segura, P
AU  - Pineda, E
AU  - Sepulveda, J M
AU  - Vieito, M
PY  - 2021
DO  - 10.1007/s12094-021-02581-1
UR  - http://hdl.handle.net/10668/17433
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - Recent advances in molecular profiling, have reclassified medulloblastoma, an undifferentiated tumor of the posterior fossa, in at least four diseases, each one with differences in prognosis, epidemiology and sensibility to different treatments. The...
LA  - en
PB  - Springer
KW  - Adults
KW  - Medulloblastoma
KW  - Treatment
KW  - Adult
KW  - Antineoplastic Agents
KW  - Cerebellar Neoplasms
KW  - Cisplatin
KW  - Combined Modality Therapy
KW  - Evidence-Based Medicine
KW  - Humans
KW  - Medical Oncology
KW  - Medulloblastoma
KW  - Molecular Targeted Therapy
KW  - Neoplasm Recurrence, Local
KW  - Palliative Care
KW  - Postoperative Complications
KW  - Prognosis
KW  - Radiotherapy
KW  - Retreatment
KW  - Societies, Medical
KW  - Spain
KW  - Vincristine
TI  - SEOM clinical guideline for management of adult medulloblastoma (2020).
TY  - research article
VL  - 23
ER  -